Computational Antibody Papers

Filter by tags
All
Filter by published year
All
TitleKey points
    • Authors investigate the role of the negative/positive binding data composition on predictive power of ab-ag interaction prediction.
    • They employ Absolut! Framework to generate synthetic binding data.
    • For binding prediction they use a 10 hidden neuron fully connected network.
    • CDR-H3 is used as a proxy for binding for computational expediency.
    • Altogether, if data in positive and negative are quite similar, there is better chance to out of distribution generalization.
    • Authors employ patent data to develop a model (selfPAD) of humanness that achieves state of the art in immunigenicity prediction.
    • They employ data from PAD which at the time were roughly 290k sequences from 16,000 patent families.
    • They recognize the noisiness inherent to the patent data and employ a training procedure to train a latent representation of patent sequences that is associated with function - in this case the target of the sequence.
    • In the first stage of training they employ contrastive learning, with sequence for the same target trained to be ‘closer’ in latent space and those against different targets to be ‘farther away’.
    • In the second stage, they perform fine tuning on humanness detection.
    • They tested their method on humanness prediction, ADA prediction and agreement with humanization choices. Taking all the tests together their method achieves the best performance.
  • 2024-08-21

    ABodyBuilder3: Improved and scalable antibody structure predictions

    • structure prediction
    • language models
    • Updated version of the popular ABodyBuilder2 program to model antibodies, that is more efficient.
    • Unlike ABB2 that did not employ language model embeddings, ABB3 does (ProtT5 to be precise).
    • Instead of using several models and aggregating the results for error prediction, they train pLDDT within the model.
    • ABB3 achieves CDR-H3 RMSD in the ballpark of 2.4Å whereas the previous version in the region of 2.5Å.
    • Authors expand the existing IMGT-mab-db with knowledge graph querying via user-friendly interface.
    • As of February 2024, IMGT/mAb-KG contains 139,629 triplets, 1,867 concepts, 114 properties, and links 21,842 entities. It includes detailed information on approximately 1,500 mAbs, 500 targets, and 500 clinical indications.
    • It is linked to various external resources, such as Thera-SAbDab, PharmGKB, PubMed, and HGNC, making it a valuable tool for researchers and developers working on therapeutic mAbs
    • It is accessible via https://www.imgt.org/mAb-KG/
    • IgDiff - antibody-specific diffusion method to generate antibody-like coordinates.
    • The method is the result of fine-tuning FrameDiff on ~150,000 antibody models (ABB2) from OAS.
    • The method supports several design scenarios, such as generating the whole Vh/Vl, just the CDRs, CDR-H3 or light chain redesign.
    • Several antibody coordinates that were generated using IgDiff and whose sequence was predicted using AbMPNN were successfully synthesized in the lab.
  • 2024-08-15

    Active learning for affinity prediction of antibodies

    • binding prediction
    • experimental techniques
    • An active learning framework is proposed to efficiently identify antibody mutations that enhance binding affinity, minimizing wet-lab experiments.
    • From the paper: “Active learning is a framework from experimental design that focuses on making informed decisions about which experiments to perform next”. That’s important these days to effectively generate prediction first data to maximize the effectiveness of models.
    • Bayesian optimization is used with relative binding free energy (RBFE) methods to iteratively propose and evaluate new antibody sequences, improving binding affinity predictions.
    • Various encoding schemes, including one-hot, bag of amino acids, BLOSUM, and AbLang2, are tested. The best performing methods are identified through validation with pre-computed data.
    • The study uses two RBFE methods: NQFEP for accurate but costly simulations, and Schrödinger Res Scan for faster but less precise results. The active learning loop consistently finds better binding sequences using these methods.
    • AbLang2 encoding with the Tanimoto kernel consistently outperformed other methods in the validation phase, indicating its effectiveness in predicting improved binding affinities.
    • NQFEP method provides more accurate but computationally expensive simulations, while the Schrödinger Res Scan offers quicker but less precise results. Despite the higher computational cost, the NQFEP method might be preferable when high accuracy is crucial.
    • Novel docking score based on graph model and language model embeddings, with an antibody-specific variety.
    • It is based on the Equiformer models, giving the structure an equivariant representation. With respect to previous work, authors moved from atom to residue-level representations, input complexes rather than single chains and provide NLP embeddings.
    • They employ DistilBert for embeddings, training it on interaction data from BioGrid.
    • The antibody specific model is trained on antibody data downloaded from ABDB to distinguish native from non-native poses after local docking with RosettaFold.
    • The antibody-specific model is in fact heavy-antigen as the authors did not see benefit in the light-only model and having it three-way heavy-light-antigen was too computationally expensive.
    • Though the antibody-specific scoring method has predictive power in distinguishing native from non-native poses.
    • The antibody-specific model did not outperform AF2-multimer, however authors note that it has predictive power that can be harnessed to rescoring AF2-multimer outputs.
    • The code is available in https://gitlab.com/mcfeemat/eudockscore
    • Authors introduce a large antibody-specific language model, Fabcon (2.4B) that demonstrably improves on predicting antibody specificity.
    • Model is based on the Falcon LLM and is trained no the CLM objective (predict next amino acid going N-to-C terminal)
    • The model was trained on paired (2.5m) and unpaired (821m) data from OAS.
    • The pre-trained model was tested on its ability to fine tune on binder prediction using three datasets anti-her2, anti-sars-cov2 and anti-il6.
    • When comparing against multiple other models on the binders prediction, the largest Fabcon model fares best, showing the benefit of overparametrization.
    • Since the model was trained on CLS objective, it can be used for sequence generation, producing sequences that are very human-like as compared to human PBMCs.
    • Inverse folding method for redesign of binding antibodies from crystal structure.
    • IgDesign draws from LM-design which introduces structural conditioning of language models. They fine-tune ProteinMPNN on Sabdab to get an antibody specific IgMPNN. The structural embeddings from IgMPNN are then used in ESM2-3B. The method receives coordinates antigen & antibody but no CDRs, as these are designed.
    • They experimentally validated the protocol on 8 antigens with co-complex in the PDB, some of which are given in the poster presenting the method: https://www.absci.com/antibody-inverse-folding/
    • They design either the CDR-h3 only or all the heavy chain CDRs. They accuracy of designs to still bind after the CDR-H3 redesign is in the ballpark of 20/30% with two outliers with 70% and 90%. Success rate of redesign of all CDRs of heavy chain is lower but in some cases even comparable to the success rate of CDR-H3 redesign alone.
    • Novel tool to automatically annotate immunoglobulin (and t-cell) genes from assemblies.
    • They compared the human manual annotations from IMGT to what they identify and they were in close agreement for functional and open reading frame genes.
    • By automating annotation, strict rules can be enforced avoiding manual curation errors.
    • Software is available at: https://github.com/williamdlees/Digger